Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2023

Resistance after IO and targeted therapies: Patterns of emergence and management

Is there a role for repeat biopsies when patients progress on targeted therapy? On Immunotherapy?

Date

30 Mar 2023

Session

Resistance after IO and targeted therapies: Patterns of emergence and management

Topics

Cancer Biology;  Translational Research;  Molecular Oncology;  Genetic and Genomic Testing

Tumour Site

Small Cell Lung Cancer;  Non-Small Cell Lung Cancer

Presenters

Valsamo Anagnostou

Authors

V. Anagnostou

Author affiliations

  • Baltimore/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A

Presenter: Zofia Piotrowska

Session: Resistance after IO and targeted therapies: Patterns of emergence and management

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.